Identification and Characterization of Antigen-Specific CD8+ T Cells Using Surface-Trapped TNF-α and Single-Cell Sequencing.

Saved in:
Bibliographic Details
Title: Identification and Characterization of Antigen-Specific CD8+ T Cells Using Surface-Trapped TNF-α and Single-Cell Sequencing.
Authors: Abdulhaqq S; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR., Ventura AB; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR., Reed JS; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR., Bashirova AA; Basic Science Program, Frederick National Laboratory for Cancer Research, Frederick, MD.; Laboratory of Integrative Cancer Immunology, Center for Cancer Research, National Cancer Institute, Bethesda, MD., Bateman KB; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR., McDonald E; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR., Wu HL; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR., Greene JM; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR., Schell JB; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR., Morrow D; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR., Wisskirchen K; Institute of Virology, Technical University of Munich/Helmholtz Zentrum Munich, Munich, Germany., Martin JN; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA., Deeks SG; HIV/AIDS Program, Department of Medicine, University of California, San Francisco, San Francisco, CA., Carrington M; Basic Science Program, Frederick National Laboratory for Cancer Research, Frederick, MD.; Laboratory of Integrative Cancer Immunology, Center for Cancer Research, National Cancer Institute, Bethesda, MD.; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, MA; and., Protzer U; Institute of Virology, Technical University of Munich/Helmholtz Zentrum Munich, Munich, Germany., Früh K; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR., Hansen SG; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR., Picker LJ; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR., Sacha JB; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR; bimber@ohsu.edu sacha@ohsu.edu.; Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, OR., Bimber BN; Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, OR bimber@ohsu.edu sacha@ohsu.edu.
Source: Journal of immunology (Baltimore, Md. : 1950) [J Immunol] 2021 Dec 15; Vol. 207 (12), pp. 2913-2921. Date of Electronic Publication: 2021 Nov 22.
Publication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 2985117R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1550-6606 (Electronic) Linking ISSN: 00221767 NLM ISO Abbreviation: J Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1550-6606
DOI:10.4049/jimmunol.2100535